Switch to:
AbbVie Inc (NYSE:ABBV)
Piotroski F-Score
7 (As of Today)

Good Sign:

Piotroski F-Score of 7 is 7, indicating very healthy situation.

The zones of discrimination were as such:

Good or high score = 8 or 9
Bad or low score = 0 or 1

AbbVie Inc has an F-score of 7 indicating the company's financial situation is typical for a stable company.

ABBV' s 10-Year Piotroski F-Score Range
Min: 6   Max: 7
Current: 7

6
7

During the past 5 years, the highest Piotroski F-Score of AbbVie Inc was 7. The lowest was 6. And the median was 6.


Definition

How is the Piotroski F-Score calculated?

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

This Year (Jun14) TTM:Last Year (Jun13) TTM:
Net Income was 1098 + 980 + 1128 + 964 = $4,170 Mil.
Cash Flow from Operations was 1717 + 624 + 1245 + 1798 = $5,384 Mil.
Revenue was 4926 + 4563 + 5111 + 4658 = $19,258 Mil.
Gross Profit was 3813 + 3463 + 3829 + 3566 = $14,671 Mil.
Total Assets at the begining of this year (Jun13) was $27,910 Mil.
Total Assets was $29,045 Mil.
Long-Term Debt was $14,470 Mil.
Total Current Assets was $17,794 Mil.
Total Current Liabilities was $6,317 Mil.
Net Income was 1068 + 968 + 1540 + 1585 = $5,161 Mil.

Revenue was 4692 + 4329 + 5206 + 4508 = $18,735 Mil.
Gross Profit was 3638 + 3176 + 3941 + 3494 = $14,249 Mil.
Total Assets at the begining of last year (Jun12) was $17,710 Mil.
Total Assets was $27,910 Mil.
Long-Term Debt was $14,326 Mil.
Total Current Assets was $15,662 Mil.
Total Current Liabilities was $6,805 Mil.

Profitability

Q1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by total assets at the beginning of the year.

Score 1 if positive, 0 if negative.

AbbVie Inc's current net income was 4,170. ==> Positive ==> Score 1.

Q2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by total assets at the beginning of the year.

Score 1 if positive, 0 if negative.

AbbVie Inc's current cash flow from operations was 5,384. ==> Positive ==> Score 1.

Q3. Change in Return on Assets

Compare this year’s return on assets (1) to last year’s return on assets.

Score 1 if it’s higher, 0 if it’s lower.

ROA (This Year)=Net Income/Total Assets at the beginning of this year (Jun13)
=4170/27910
=0.14940881

ROA (Last Year)=Net Income/Total Assets at the beginning of last year (Jun12)
=5161/17709.554
=0.29142462

AbbVie Inc's return on assets of this year was 0.14940881. AbbVie Inc's return on assets of last year was 0.29142462. ==> Last year is higher ==> Score 0.

Q4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA =< ROA.

AbbVie Inc's current net income was 4,170. AbbVie Inc's current cash flow from operations was 5,384. ==> 5,384 > 4,170 ==> CFROA > ROA ==> Score 1.

Funding

Q5. Change in Gearing or Leverage

Compare this year’s gearing (long-term debt divided by average total assets) to last year’s gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year)=Long-Term Debt/Total Assets
=14470/29045
=0.49819246

Gearing (Last Year)=Long-Term Debt/Total Assets
=14326/27910
=0.51329273

AbbVie Inc's gearing of this year was 0.49819246. AbbVie Inc's gearing of last year was 0.51329273. ==> This year is lower or equal to last year. ==> Score 1.

Q6. Change in Working Capital (Liquidity)

Compare this year’s current ratio (current assets divided by current liabilities) to last year’s current ratio.

Score 1 if this year'’s current ratio is higher, 0 if it’s lower

Current Ratio (This Year)=Total Current Assets/Total Current Liabilities
=17794/6317
=2.81684344

Current Ratio (Last Year)=Total Current Assets/Total Current Liabilities
=15662/6805
=2.30154298

AbbVie Inc's current ratio of this year was 2.81684344. AbbVie Inc's current ratio of last year was 2.30154298. ==> This year's current ratio is higher. ==> Score 1.

Q7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

AbbVie Inc's number of shares in issue this year was 1608. AbbVie Inc's number of shares in issue last year was 1609. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Q8. Change in Gross Margin

Compare this year’s gross margin (gross profit divided by sales) to last year’s.

Score 1 if this year’s gross margin is higher, 0 if it’s lower.

Gross Margin (This Year)=Gross Profit/Revenue
=14671/19258
=0.76181327

Gross Margin (Last Year)=Gross Profit/Revenue
=14249/18735
=0.76055511

AbbVie Inc's gross margin of this year was 0.76181327. AbbVie Inc's gross margin of last year was 0.76055511. ==> This year's gross margin is higher. ==> Score 1.

Q9. Change in asset turnover

Compare this year’s asset turnover (total sales divided by total assets at the beginning of the year) to last year’s asset turnover ratio.

Score 1 if this year’s asset turnover ratio is higher, 0 if it’s lower

Asset Turnover (This Year)=Revenue/Total Assets at the beginning of this year (Jun13)
=19258/27910
=0.69000358

Asset Turnover (Last Year)=Revenue/Total Assets at the beginning of last year (Jun12)
=18735/17709.554
=1.05790355

AbbVie Inc's asset turnover of this year was 0.69000358. AbbVie Inc's asset turnover of last year was 1.05790355. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score=Q1+Q2+Q3+Q4+Q5+Q6+Q7+Q8+Q9
=1+1+0+1+1+1+1+1+0
=7

Good or high score = 8 or 9

Bad or low score = 0 or 1

AbbVie Inc has an F-score of 7 indicating the company's financial situation is typical for a stable company.


Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Related Terms

Net Income, Cash Flow from Operations, Revenue, Gross Profit, Total Assets, Long-Term Debt, Total Current Assets, Total Current Liabilities


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

AbbVie Inc Annual Data

Dec09Dec10Dec11Dec12Dec13
Q1 1
Q2 1
Q3 0
Q4 1
Q5 1
Q6 1
Q7 0
Q8 1
Q9 0
F-score 6

AbbVie Inc Quarterly Data

Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14Jun14
Q1 111
Q2 111
Q3 000
Q4 111
Q5 111
Q6 111
Q7 001
Q8 111
Q9 000
F-score 0000000667
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK